Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase in mean survival days of host at 10 mg/kg, sc administered 72 hrs after infection relative to control
Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase in mean survival days of host at 5 mg/kg, sc administered 72 hrs after infection relative to control
Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase in mean survival days of host at 2.5 mg/kg, sc administered 72 hrs after infection relative to control
Antimalarial activity against Plasmodium berghei infected in mouse assessed as increase in mean survival days of host at 1.25 mg/kg, sc administered 72 hrs after infection relative to control
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 640 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 320 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 160 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 80 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 40 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against Plasmodium berghei infected in mouse assessed as disease cure from parasite infection at 20 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as daily dose required to suppression of 90% parasite infection administered with diet for 6 days
Ratio of quinine hydrochloride SD90 to compound SD90 for trophozoite-induced Plasmodium berghei infected in mouse assessed as daily dose required to suppression of 90% parasite infection administered with diet for 6 days
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as disease cure from parasite infection at 320 mg/kg, sc administered 72 hrs after infection
Toxicity in sporozoite-induced Plasmodium gallinaceum infected white leghorn chicken assessed as mortality at 320 mg/kg, sc administered 72 hrs after infection measured up to 6 days
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as disease cure from parasite infection at 160 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as disease cure from parasite infection at 80 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as disease cure from parasite infection at 40 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as increase in mean survival days of host at 20 mg/kg, sc administered 72 hrs after infection relative to control
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as disease cure from parasite infection at 20 mg/kg, sc administered 72 hrs after infection
Antimalarial activity against sporozoite-induced Plasmodium gallinaceum infected in white leghorn chicken assessed as increase in mean survival days of host at 10 mg/kg, sc administered 72 hrs after infection relative to control